ViaZen
Inflammation
Dosage
and treatment time duration:
Chronic
Inflammation:
1 capsule 3 times a day with food during at least 3 months.
Acute
Inflammation:
1 à 2 capsules every 4 hours with food until symptoms relief.
Specific
therapeutic indications:
-
Ankylosing
spondylitis
-
Arthritis
-
Arthrosis
-
Bursitis
-
Gout
-
Osteoarthritis
-
Sciatica
-
Tendinitis
Other
indications :
Since
Viazen Inflammation is an anti-inflammatory drug with broad
spectrum of action, it is also recommended under the following
conditions:
-
Bowel Inflammatory diseases:
-
Asthma, rhinitis, chronic sinusitis.
-
Eczema, psoriasis, urticaria.
-
Ovulation and menstrual pain.
-
Headaches and migraines.
Note:
Viazen Inflammation is free of wheat, soya, corn, yeast, peanut,
gluten, egg and dairy products. It does not contain
preservatives, sweeteners, colouring agents, artificial flavours
and is exempt of GMO.
Mechanism of action:
Viazen Inflammation is a powerful natural anti-inflammatory with
broad spectrum of action. The synergistic action of the four
scientifically recognized medicinal substances effectively
inhibits the production of pro-inflammatory substances.
The curcuminoides are responsible of the turmeric
anti-inflammatory properties, in several ways. They inhibit the
synthesis of the enzymes (lipoxygenase and cyclooxygenase) which
take part in the synthesis of pro-inflammatory substances
derived from the arachidonic acid.
They also inhibit the tumour necrosis factor (TNF-alpha), the
interleukine 8, the interleukine 1B, the thromboxane B2 and the
leukotriene B4. Within the macrophages, the curcuminoides
prevent arachidonic acid incorporation in lipids membranes, as
well as E2 prostaglandin, B4 leukotriene and C4 leukotriene.
They prevent also the secretion of collagenase, elastase, and
hyaluronidase. They block the transcription of the molecules of
adhesion of the leucocytes induced by several cytokines. The
boswellic acids are the main anti-inflammatory components of the
boswellia.
They inhibit the infiltration of the polymorphonuclear
leucocytes (PMN) and the inflammatory answer induced by TNF-alpha.
Moreover, the boswellic acids have analgesic and antipyretic
properties. It seems that the boswellia would have also a
reducing effect on conjunctive tissues degradation.
The bromelain inhibits the biosynthesis of pro-inflammatory
prostaglandins by reducing the presence of bradykinine. Zinc is
an important enzymatic cofactor necessary to the activation of
more than 300 different enzymes. It will also take part in the
healing process of tissues damaged by the inflammation process.
Oxidative stress (excess of free radicals compared to
antioxidants) figures among the causes of the inflammatory
disease. Viazen Inflammation will help to reduce the harmful
effect of the free radicals by the antioxidant properties of the
turmeric on the peroxides and phenolic free radicals and by its
inhibiting effect of the nitric acid. Zinc will also provide an
antioxidant protection as a cofactor necessary to the
antioxidant superoxide dismutase (SOD) activation.
The ingredients’ synergy of Viazen Inflammation is the key of
the effectiveness of this SUPERIOR FORMULA.
References :
Gagnon R. La Nutrithérapie. Collection Douce Alternative,
Amyris. 2004. 287 pages. MacKay D. Miller AL. Altern Med Rev.
2003. Nov;8(4):359-77. Kulkarni RR et al. Treatment of
osteoarthritis with a herbomineral formulation: a double-blind,
placebo-controlled, cross-over study. J Etnopharmacol. 1991
May-Jun ;33(1-2) :91-5. Kulkarni RR et al. Efficacy of an
ayurvedic formulation in rheumatoid arthritis: a double-blind,
placebo-controlled, cross-over study. Indian Journal of
Pharmacology.
1992;24:98-101. Reddy Gk et al.
Studies
on the metabolism of glycosaminoglycans under the influence of
new herbal anti-inflammatory agents. Biochem Pharmacol.
1989 Oct
15;38(20):3527-34. Kimmatkar N et al.
Efficacy
and tolerability of Boswellia serrata extract in treatment of
osteoarthritis of knee – a randomized double blind placebo
controlled trial. Phytomedicine. 2003 Jan;10(1):3-7.
www.arthrite.ca / www.cihr-irsc.gc.ca/f/35184.html /
www.naturaldatabase.com
/
www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/monograph/mono_list_f.html#m.
/www.naturalstandard.com |
